Position in ASND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$448,046,159
-$205,309,046 QoQ
Shares Held
1,958,843
-36.1% QoQ
Ownership
2.99%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Capital International Investors holds $7,233,634,148 across 15 Biotechnology names. ASND ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,126,077 | $2,288,998,423 | |
| 2 | RPRX |
Royalty Pharma plc
|
35,005,736 | $1,679,225,155 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
4,158,726 | $1,235,016,860 | |
| 4 | INSM |
INSMED Inc
|
5,595,194 | $914,926,122 | |
| 5 | ASND |
Ascendis Pharma A/S
This page
|
1,958,843 | $448,046,159 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
2,674,727 | $155,535,375 | |
| 7 | RAPP |
Rapport Therapeutics, Inc.
|
3,097,973 | $96,935,575 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,338,803 | $88,240,505 |
All Filings in ASND
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $448,046,159 | 1,958,843 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $653,355,205 | 3,063,943 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $608,481,066 | 3,060,616 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $525,900,290 | 3,046,931 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $448,065,081 | 2,874,792 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $394,183,489 | 2,863,249 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $314,953,020 | 2,109,390 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $286,984,161 | 2,104,298 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $331,260,635 | 2,191,312 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $274,730,704 | 2,181,268 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $203,053,002 | 2,168,443 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $178,077,936 | 1,995,271 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $213,271,945 | 1,989,106 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $191,499,473 | 1,567,997 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $136,246,510 | 1,319,451 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $121,500,672 | 1,307,021 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $28,894,266 | 246,202 | Shares | Defined | 2022-05-19 | |
| No filing history on record for this holder in this stock. | ||||||